A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Status:
Recruiting
Trial end date:
2023-12-14
Target enrollment:
Participant gender:
Summary
This study will test an investigational drug called AZD1390 in combination with radiation
therapy for the treatment of brain tumors. This is the first time AZD1390 is being given to
patients. This study will test safety, tolerability and PK (how the drug is absorbed,
distributed and eliminated) of ascending doses of AZD1390 in combination with distinct
regimens of radiation therapy